BOSTON, MA & VANCOUVER, BC — Eckert & Ziegler (ISIN DE0005659700, SDAX) and Alpha-9 Theranostics Inc. (Alpha-9), a radiopharmaceutical company with offices in Vancouver and Boston, have signed an agreement… Read More
Data to be presented at IDWeek 2022 showed overall vaccine efficacy against RSV-lower respiratory tract disease (LRTD) in adults aged 60 years and above, with a favourable safety profile Consistent… Read More
The $1.5 million award is to evaluate the ability of NervGen’s NVG-291-R to accelerate and enhance restoration of function following peripheral nerve injury (PNI) The research is to support a… Read More
Knowledge Translation (KT) activities aim to close the gap between research and implementation by improving the use of research evidence in practice, policy and further research. Through our 2022 Convening… Read More
Represents second Phase 2 program for EP-104IAR, with initial data readout anticipated in H1, 2023- VICTORIA, BC, Oct. 12, 2022 — Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX), a… Read More
